A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome

References

• Center for Disease Control and Prevention. Key findings: public health reporting of NAS offers opportunities for treatment and prevention 2021; 2021 [cited 2021 Jan 27]. Available from: https://www.cdc.gov/pregnancy/features/public-health-reporting-of-NAS.html
   Google Scholar
• Patrick SW, Burke JF, Biel TJ, et al. Risk of hospital readmission among infants with neonatal abstinence syndrome. Hosp Pediatr. 2015;5(10):513–519.
   PubMedGoogle Scholar
• Agency for Healthcare Research and Quality. Neonatal abstinence syndrome (NAS) among newborn hospitalizations 2021; 2021 [cited 2021 Feb 7]. Available from: https://www.hcup-us.ahrq.gov/faststats/NASMap
   Google Scholar
• Strahan AE, Guy GP Jr., Bohm M, et al. Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatr. 2020;174(2):200–202.
   PubMed Web of Science ®Google Scholar
• Brown JD, Goodin AJ, Talbert JC. Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment. J Rural Health. 2018;34(1):6–13.
   PubMed Web of Science ®Google Scholar
• Kroelinger CD, Addison D, Rodriguez M, et al. Implementing a learning collaborative framework for states working to improve outcomes for vulnerable populations: the opioid use disorder, maternal outcomes, and neonatal abstinence syndrome initiative learning community. J Womens Health. 2020;29(4):475–486.
   Web of Science ®Google Scholar
• Center for Disease Control and Prevention. U.S. opioid dispensing rate maps; 2021 [cited 2022 Jan 27]. Available from: https://www.cdc.gov/drugoverdose/rxrate-maps/index.html
   Google Scholar
• Pourcyrous M, Elabiad MT, Rana D, et al. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure. Pediatr Res. 2021;90(2):459–463.
   PubMed Web of Science ®Google Scholar
• Winkelman TNA, Villapiano N, Kozhimannil KB, et al. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004–2014. Pediatrics. 2018;141(4):e20173520.
   PubMed Web of Science ®Google Scholar
• Uebel H, Wright IM, Burns L, et al. Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics. 2015;136(4):e811–e820.
   PubMed Web of Science ®Google Scholar
• Witt CE, Rudd KE, Bhatraju P, et al. Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington State: a retrospective cohort study. J Perinatol. 2017;37(10):1124–1129.
   PubMed Web of Science ®Google Scholar
• Milliren CE, Melvin P, Ozonoff A. Pediatric hospital readmissions for infants with neonatal opioid withdrawal syndrome, 2016–2019. Hosp Pediatr. 2021;11(9):979–988.
   PubMedGoogle Scholar
• Center for Disease Control and Prevention. Drug overdose mortality by state 2021; 2021 [cited 2021 Aug 25]. Available from: https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm
   Google Scholar
• U.S. Census Bureau; 2021 [cited 2021 Jan 27]. Available from: https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf
   Google Scholar
• Goyal S, Saunders KC, Moore CS, et al. Identification of substance-exposed newborns and neonatal abstinence syndrome using ICD-10-CM – 15 hospitals, Massachusetts, 2017. MMWR Morb Mortal Wkly Rep. 2020;69(29):951–955.
   PubMed Web of Science ®Google Scholar
• Agency of Healthcare Research and Quality. Clinical Classifications Software Refined (CCSR); 2021 [cited 2022 Jan 27]. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp
   Google Scholar
• Van Horn A, Powell W, Wicker A, et al. Outpatient healthcare access and utilization for neonatal abstinence syndrome children: a systematic review. J Clin Transl Sci. 2019;4(5):389–397.
   PubMedGoogle Scholar
• Puls HT, Anderst JD, Farst K, et al. Intrauterine substance exposure and the risk for subsequent physical abuse hospitalizations. Acad Pediatr. 2020;20(4):468–474.
   PubMed Web of Science ®Google Scholar
• Health Resources and Service Administration. Medical underserved populations find; 2021 [cited 2022 Feb 1]. Available from: https://data.hrsa.gov/tools/shortage-area/mua-find
   Google Scholar
• Jackson A, Shannon L. Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Matern Child Health J. 2012;16(9):1762–1770.
   PubMed Web of Science ®Google Scholar
• Wiles JR, Isemann B, Ward LP, et al. Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure. J Pediatr. 2014;165(3):440–446.
   PubMed Web of Science ®Google Scholar
• Chau KT, Nguyen J, Miladinovic B, et al. Outpatient management of neonatal abstinence syndrome: a quality improvement project. Jt Comm J Qual Patient Saf. 2016;42(11):506–515.
   PubMedGoogle Scholar
• Lai A, Philpot P, Boucher J, et al. An outpatient methadone weaning program by a neonatal intensive care unit for neonatal abstinence syndrome. Popul Health Manag. 2017;20(5):397–401.
   PubMed Web of Science ®Google Scholar
• Backes CH, Backes CR, Gardner D, et al. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol. 2012;32(6):425–430.
   PubMed Web of Science ®Google Scholar
• Murphy-Oikonen J, McQueen K. Outpatient pharmacologic weaning for neonatal abstinence syndrome: a systematic review. Prim Health Care Res Dev. 2018;20:e76.
   PubMed Web of Science ®Google Scholar
• Smirk CL, Bowman E, Doyle LW, et al. Home-based detoxification for neonatal abstinence syndrome reduces length of hospital admission without prolonging treatment. Acta Paediatr. 2014;103(6):601–604.
   PubMed Web of Science ®Google Scholar
• Oei J, Feller JM, Lui K. Coordinated outpatient care of the narcotic-dependent infant. J Paediatr Child Health. 2001;37(3):266–270.
   PubMed Web of Science ®Google Scholar
• Kelly LE, Knoppert D, Roukema H, et al. Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study. Paediatr Drugs. 2015;17(2):151–157.
   PubMed Web of Science ®Google Scholar
• Dickes L, Summey J, Mayo R, et al. Potential for Medicaid savings: a state and national comparison of an innovative neonatal abstinence syndrome treatment model. Popul Health Manag. 2017;20(6):458–464.
   PubMed Web of Science ®Google Scholar
• National Center on Substance Abuse and Child Welfare. Plan of Safe Care; 2021 [cited 2022 Feb 3]. Available from: https://reporter.nih.gov/search/ha8K0fKpKEmXcJ-BvgDVrQ/project-details/10379584
   Google Scholar
• Schroeder M, editor. Kentucky’s comprehensive system of care model for pregnant and parenting women with SUD. Atlanta (GA): National Drug Abuse and Heroin Summit; 2018.
   Google Scholar
• Ma TX. SAFE4BOTH integration of mobile technologies with case management (CM) systems provide education, work flow among multiple stakeholders to implement Plan of Safe Care (POSC) for SUD mom and infants; 2021 [cited 2022 Feb 3]. Available from: https://reporter.nih.gov/search/-6OTOoEVw0yA9rrj58_0Ww/project-details/9908839
   Google Scholar
• Kentucky Department of Public Health Maternal and Child Health. Annual report 2019 public health neonatal abstinence syndrome reporting registry; 2020 [cited 2022 Mar 1]. Available from: https://chfs.ky.gov/agencies/dph/dmch/Documents/NASReport.pdf
   Google Scholar
• Commonwealth of Kentucky Justice & Public Safety Cabinet. 2020 overdose fatality report Kentucky office of drug control policy; 2021. Available from: https://odcp.ky.gov/Documents/2020%20KY%20ODCP%20Fatality%20Report%20.(final).pdf
   Google Scholar